CM Hospitalar S/A (VVEO3.SA)
- Previous Close
1.2000 - Open
0.0000 - Bid 1.2300 x --
- Ask 1.2400 x --
- Day's Range
0.0000 - 0.0000 - 52 Week Range
0.0000 - 5.6500 - Volume
0 - Avg. Volume
1,807,832 - Market Cap (intraday)
391.602M - Beta (5Y Monthly) 0.09
- PE Ratio (TTM)
-- - EPS (TTM)
-4.4600 - Earnings Date --
- Forward Dividend & Yield 0.14 (11.01%)
- Ex-Dividend Date May 2, 2024
- 1y Target Est
2.16
CM Hospitalar S/A engages in the distribution of hospital materials, medicines, and nutrition products in Brazil. The company offers ophthalmic agent, adrenergic and thrombopoietin agonist, aminoglycosides, painkiller, anesthetics, receptor antagonist, anti-hemorrhoidal, antihypertensives, systemic antihistamine, and orthopedic therapy materials; and anti-inflammatories, anti-TNF, antacid, antiandrogen, antianemic, anti-asthmatic, antibiotic, anticoagulant, anticonvulsant, monoclonal antibody, anti-growth, antidepressant, antidiabetic, antidiuretic, antidote, antiemetics and antinauseants, anti-migraine, antiepileptics, antiestrogens, antifibrinolytic, antiflatulent, antifungal, antihemorrhagic, antimicrobial, antineoplastics, antiparathyroid drugs, antiparkinsonian, antipsychotic, systemic antipsoriasis, antirheumatics, anti-varicose, and antiviral medicines. It also provides beta blocker, carbohydrate, cycloplegic, contraceptive, contrast, special control, corticosteroid, topical debrider, diuretic, electrolyte, pancreatic enzyme, erythropoietin, uterine and cardiac stimulant, growth factor, granulocyte colony stimulating factor, gastroprokinetic, systemic hemostatic, heparins, hepatoprotector and lipotropic, hormone, adeno-pituitary and growth hormone, immunoglobulin, immunosuppressant, labor inducer, proton pump and phosphodiesterase inhibitor, bone resorption inhibitor, platelet aggregation inhibitor, adenosine diphosphate receptor antagonist, proton pump and interleukin inhibitor, proprotein convertase subtilisin/kexin type 9 inhibitor, and calcium reabsorption inhibitor medicines. In addition, the company distributes orthopedic products, compression socks, and diapers; and transports medical and hospital cargo. Further, it provides support infrastructure and assistance, as well as pharmaceutical monitoring to patients at home; and wipes and wet towels. CM Hospitalar S/A was founded in 2010 and is headquartered in Ribeirão Preto, Brazil.
www.mafrasaude.com.br6,000
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: VVEO3.SA
View MorePerformance Overview: VVEO3.SA
Trailing total returns as of 4/24/2025, which may include dividends or other distributions. Benchmark is IBOVESPA (^BVSP) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: VVEO3.SA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: VVEO3.SA
View MoreValuation Measures
Market Cap
391.60M
Enterprise Value
3.46B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.03
Price/Book (mrq)
0.20
Enterprise Value/Revenue
0.30
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-12.22%
Return on Assets (ttm)
-5.16%
Return on Equity (ttm)
-54.28%
Revenue (ttm)
11.58B
Net Income Avi to Common (ttm)
-1.42B
Diluted EPS (ttm)
-4.4600
Balance Sheet and Cash Flow
Total Cash (mrq)
1.13B
Total Debt/Equity (mrq)
217.75%
Levered Free Cash Flow (ttm)
-85.56M